A randomized clinical trial of an inactivated avian influenza A (H7N7) vaccine.
Concern for a pandemic caused by a newly emerged avian influenza A virus has led to clinical trials with candidate vaccines as preparation for such an event. Most trials have involved vaccines for influenza A (H5N1), A (H7N7) or A (H9N2).To evaluate dosage-related safety and immunogenicity of an ina...
Main Authors: | Robert B Couch, Shital M Patel, Chianti L Wade-Bowers, Diane Niño |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3519847?pdf=render |
Similar Items
-
Evaluations for in vitro correlates of immunogenicity of inactivated influenza a H5, H7 and H9 vaccines in humans.
by: Robert B Couch, et al.
Published: (2012-01-01) -
An avian influenza H7 DNA priming vaccine is safe and immunogenic in a randomized phase I clinical trial
by: Adam D. DeZure, et al.
Published: (2017-06-01) -
Hemagglutinin-Specific Non-neutralizing Antibody Is Essential for Protection Provided by Inactivated and Viral-Vectored H7N9 Avian Influenza Vaccines in Chickens
by: Zenglei Hu, et al.
Published: (2020-01-01) -
Studies on the development of adjuvants and inactivated vaccines of avian influenza
by: DAI, SHI-YUAN, et al.
Published: (1993) -
Dynamics Analysis of an Avian Influenza A (H7N9) Epidemic Model with Vaccination and Seasonality
by: Juping Zhang, et al.
Published: (2019-01-01)